Ha habido 50 transacciones internas recientes registradas para Brainstorm Cell Therapeutics Inc. (BCLI), incluyendo 44 compras y 1 venta. El total de compras internas fue valorado en $575.32K y el total de ventas internas en $22.07K.
Internos destacados con actividad reciente incluyen Hartounian Hartoun, Frenkel Jacob A, Arbel Irit. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — BCLI
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2025-01-01 |
Hartounian Hartoun |
EVP, Chief Operating Officer |
Concesión de RSU |
50,000 |
- |
- |
52,000 |
| 2025-01-01 |
Frenkel Jacob A |
Director |
Concesión de RSU |
40,000 |
- |
- |
43,777 |
| 2025-01-01 |
Arbel Irit |
Director |
Concesión de RSU |
30,666 |
- |
- |
41,054 |
| 2025-01-01 |
Lebovits Chaim |
President & CEO |
Concesión de RSU |
120,000 |
- |
- |
200,960 |
| 2025-01-01 |
Yablonka Uri |
EVP & Chief Business Officer |
Concesión de RSU |
40,000 |
- |
- |
48,464 |
| 2025-01-01 |
Patlis Alla |
See Remarks |
Concesión de RSU |
40,000 |
- |
- |
44,349 |
| 2025-01-01 |
Polverino Anthony J. |
Director |
Concesión de RSU |
24,000 |
- |
- |
25,730 |
| 2025-01-01 |
Lindborg Stacy |
Director |
Concesión de RSU |
20,000 |
- |
- |
48,229 |
| 2025-01-01 |
Bairu Menghisteab |
Director |
Concesión de RSU |
24,000 |
- |
- |
24,000 |
| 2025-01-01 |
Naor Nir |
Director |
Concesión de RSU |
30,666 |
- |
- |
31,465 |
| 2025-01-01 |
Dagher Ibrahim B. |
Chief Medical Officer |
Concesión de RSU |
50,000 |
- |
- |
66,849 |
| 2024-10-01 |
Lebovits Chaim |
President & CEO |
Compra Informativa |
1,836 |
$3.43 |
$6.29K |
80,960 |
| 2024-09-30 |
Lebovits Chaim |
President & CEO |
Compra Informativa |
22,000 |
$0.23 |
$5.02K |
1,186,865 |
| 2024-07-19 |
Dagher Ibrahim B. |
Chief Medical Officer |
Venta Informativa |
63,000 |
$0.35 |
$22.07K |
- |
| 2024-06-24 |
Hartounian Hartoun |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-06-24 |
Hartounian Hartoun |
EVP, Chief Operating Officer |
Concesión de RSU |
30,000 |
- |
- |
30,000 |
| 2024-05-28 |
Lebovits Chaim |
President & CEO |
Concesión de RSU |
15,000 |
$0.52 |
$7.77K |
1,164,865 |
| 2024-05-28 |
Lebovits Chaim |
President & CEO |
Compra Informativa |
15,000 |
$0.52 |
$7.77K |
1,164,865 |
| 2024-05-22 |
Lebovits Chaim |
President & CEO |
Concesión de RSU |
25,000 |
$0.64 |
$16K |
1,149,865 |
| 2024-05-22 |
Lebovits Chaim |
President & CEO |
Compra Informativa |
25,000 |
$0.64 |
$16K |
1,149,865 |
| 2024-05-21 |
Lebovits Chaim |
President & CEO |
Concesión de RSU |
25,000 |
$0.58 |
$14.48K |
1,124,865 |
| 2024-05-21 |
Lebovits Chaim |
President & CEO |
Compra Informativa |
25,000 |
$0.58 |
$14.48K |
1,124,865 |
| 2024-05-13 |
Lebovits Chaim |
President & CEO |
Concesión de RSU |
10,000 |
$0.49 |
$4.9K |
1,099,865 |
| 2024-05-13 |
Lebovits Chaim |
President & CEO |
Compra Informativa |
10,000 |
$0.49 |
$4.9K |
1,099,865 |
| 2024-05-11 |
Lebovits Chaim |
President & CEO |
Concesión de RSU |
10,000 |
$0.47 |
$4.67K |
1,089,865 |
| 2024-05-11 |
Lebovits Chaim |
President & CEO |
Compra Informativa |
10,000 |
$0.47 |
$4.67K |
1,089,865 |
| 2024-05-10 |
Lebovits Chaim |
President & CEO |
Concesión de RSU |
20,000 |
$0.47 |
$9.3K |
1,079,865 |
| 2024-05-10 |
Lebovits Chaim |
President & CEO |
Compra Informativa |
20,000 |
$0.47 |
$9.3K |
1,079,865 |
| 2024-05-07 |
Lebovits Chaim |
President & CEO |
Concesión de RSU |
66,300 |
$0.37 |
$24.82K |
1,059,865 |
| 2024-05-07 |
Lebovits Chaim |
President & CEO |
Compra Informativa |
66,300 |
$0.37 |
$24.82K |
1,059,865 |
| 2024-05-06 |
Lebovits Chaim |
President & CEO |
Concesión de RSU |
135,000 |
$0.38 |
$50.67K |
993,565 |
| 2024-05-06 |
Lebovits Chaim |
President & CEO |
Compra Informativa |
135,000 |
$0.38 |
$50.67K |
993,565 |
| 2024-04-19 |
Lebovits Chaim |
President & CEO |
Concesión de RSU |
15,000 |
$0.52 |
$7.8K |
858,565 |
| 2024-04-19 |
Lebovits Chaim |
President & CEO |
Compra Informativa |
15,000 |
$0.52 |
$7.8K |
858,565 |
| 2024-04-18 |
Lebovits Chaim |
President & CEO |
Concesión de RSU |
115,072 |
$0.53 |
$60.47K |
843,565 |
| 2024-04-18 |
Lebovits Chaim |
President & CEO |
Compra Informativa |
115,072 |
$0.53 |
$60.47K |
843,565 |
| 2024-04-17 |
Dagher Ibrahim B. |
Chief Medical Officer |
Desconocido |
80,000 |
$1.73 |
$138.4K |
- |
| 2024-04-17 |
Lebovits Chaim |
President & CEO |
Concesión de RSU |
130,000 |
$0.55 |
$70.94K |
728,493 |
| 2024-04-17 |
Dagher Ibrahim B. |
Chief Medical Officer |
Desconocido |
- |
- |
- |
30,000 |
| 2024-04-17 |
Lebovits Chaim |
President & CEO |
Compra Informativa |
130,000 |
$0.55 |
$70.94K |
728,493 |
| 2024-03-11 |
Lebovits Chaim |
President & CEO |
Concesión de RSU |
305,198 |
- |
- |
598,493 |
| 2024-03-11 |
Yablonka Uri |
EVP & Chief Business Officer |
Concesión de RSU |
109,426 |
- |
- |
126,969 |
| 2024-03-11 |
Patlis Alla |
See Remarks |
Concesión de RSU |
65,246 |
- |
- |
65,246 |
| 2024-03-11 |
Lindborg Stacy |
Co-chief Executive Officer |
Concesión de RSU |
241,935 |
- |
- |
423,435 |
| 2023-09-01 |
Lindborg Stacy |
Co-chief Executive Officer |
Compra Informativa |
11,500 |
$1.77 |
$20.4K |
181,500 |
| 2023-08-02 |
Lebovits Chaim |
President & CEO |
Concesión de RSU |
31,185 |
- |
- |
293,295 |
| 2023-08-02 |
Lindborg Stacy |
Co-chief Executive Officer |
Concesión de RSU |
35,000 |
- |
- |
170,000 |
| 2023-06-19 |
Naor Nir |
Director |
Desconocido |
- |
- |
- |
- |
| 2023-06-19 |
Naor Nir |
Director |
Concesión de RSU |
11,999 |
- |
- |
11,999 |
| 2023-05-01 |
Taylor Kirk |
Officer |
Desconocido |
- |
- |
- |
- |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
